Skip to Content
Simtra BioPharma Solutions Home

News & Events

Stay up to date on the latest news about our business and on events our team will be attending.

Upcoming Events

October 25-28, 2026

New Orleans, LA

AAPS 2026 PHarmSCi 360

Booth: #1938

March 8-11, 2027

London, UK

World ADC – London

March 15-18, 2027

New York, NY

DCAT Week 2027

News

18 Results Found

  • News

    How Simtra Is Scaling for the GLP-1 Manufacturing Boom

    As the GLP-1 boom reshapes demand for sterile injectable manufacturing, Chief Commercial Officer Mike Schaefers explains how CDMOs are scaling capacity, cold-chain capabilities and regional production to keep pace with the speed of innovation in today's drug pipelines.
  • News

    Simtra Experts Highlight the Future of CDMO Partnerships.

    How can biopharmaceutical companies manage growing manufacturing complexity while accelerating the path to patients? In PHARMAnetwork Magazine, Simtra BioPharma Solutions leaders Franco Negron, Pat Adams, Rob Perry and Vincent Mancuso outline the CDMO capabilities that will matter most, from scalable capacity to supply chain resilience.
  • News

    New PMPS Article Explores Strategies for Expanding Capacity Without Compromise

    In a new article for Pharmaceutical Manufacturing & Packing Sourcer, Pat Adams, Vice President of Expansion Operations at Simtra BioPharma Solutions, draws on lessons from Simtra's Bloomington expansion to outline strategies for accelerating manufacturing capacity, from agile project execution to workforce readiness.
  • News

    How Simtra BioPharma Solutions is Advancing Efficiency Through Expertise

    In an article for Drug Development & Delivery, Greg Sacha, Global Senior Scientist at Simtra BioPharma Solutions, details how a data-driven Design of Experiments (DoE) approach to formulation and process development can help biopharma companies work more efficiently across both large and small molecules. The approach reduces iterations, minimizes material use, and accelerates timelines, giving emerging companies a faster, more controlled path from development to commercial-scale manufacturing.
  • News

    Five Ways To Unleash The Potential Of Women In STEM

    In Life Science Leader, Lidia Serina, Ph.D., shares five powerful lessons to help women in STEM thrive—highlighting the importance of self-advocacy, boundaries, and showing up authentically.
  • News

    Inside Pharma and BioPharma Outsourcing: CDMO Leadership Perspectives

    In this live recording from DCAT, our CEO Franco Negron speaks with Raman Sehgal, host of the "Molecule to Market" podcast, and Alessandro Maselli, President and CEO of Catalent, about the transformation of CDMOs from enablers to systemically important partners. Hosted by Morgan Stanley, the panel addressed the latest issues in global drug manufacturing and development, including how the pace of scientific innovation is changing the market and the value of strategic use of AI for both customers and employees.
  • News

    How ADCs and GLP-1s Are Shaping the Future of the Injectables Market

    In this Health Tech World podcast, Lupe Rojas and Sean Knight of Simtra’s business development team explore the evolution of the injectables market and manufacturing demand for sterile injectable therapies, from ADCs in oncology to GLP‑1 weight‑loss drugs.The conversation takes a deeper look at the factors influencing how CDMOs are structuring their supply chains to meet the global demand.

     
  • News

    DCAT Week 2026: What Is Driving the Pace of Injectable Capacity Investment?

    Simtra BioPharma Solutions CEO Franco Negron sat down with BioPharma International during DCAT to talk about the key drivers behind our growth strategy and how we stay ahead of evolving market trends. Discover the rationale behind our recent investments — and how they position Simtra to better support our clients and their patients.
  • News

    Inside Simtra’s Growth Strategy

    In this new article for Contract Pharma, Simtra BioPharma Solutions CEO Franco Negron discusses how we combine our legacy of 65+ years of experience in manufacturing sterile injectables with a culture of continuous improvement and workforce development. When it comes to investing in new technology like AI, he says, “Our goal is not to replace people but to improve outcomes, strengthen customer service and develop our workforce.” Read more about the market forces — and the strategy — driving our growth.

Showing 1 to 9 of 18 news

Contact Us

For media inquiries, please contact [email protected]